See more : Traeger, Inc. (COOK) Income Statement Analysis – Financial Results
Complete financial analysis of Lier Chemical Co.,LTD. (002258.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lier Chemical Co.,LTD., a leading company in the Chemicals industry within the Basic Materials sector.
- Osisko Gold Royalties Ltd (OR.TO) Income Statement Analysis – Financial Results
- Singamas Container Holdings Limited (0716.HK) Income Statement Analysis – Financial Results
- Tarapur Transformers Limited (TARAPUR.NS) Income Statement Analysis – Financial Results
- Cowen Inc. (COWN) Income Statement Analysis – Financial Results
- Multibase India Limited (MULTIBASE.BO) Income Statement Analysis – Financial Results
Lier Chemical Co.,LTD. (002258.SZ)
About Lier Chemical Co.,LTD.
Lier Chemical Co.,LTD. engages in the research and development, production, and sale of agrochemical products in the People's Republic of China and internationally. The company offers low-toxicity and low-residue safe pesticides, such as chloropyridines and organophosphates. It also provides herbicides, including pinoxaden, glufosinate-ammonium, diquat, flumioxazin, clodinafop-propargyl, clopyralid acid, picloram, fluroxypyr-meptyl, triclopyr, diuron, bensulfuron-methyl, linuron, pyrazosulfuron-ethyl, nicosulfuron, flufenacet, mefenacet, and quinclorac; fungicides, such as azoxystrobin, epoxiconazole, iprodione, and difenoconazole; and insecticides comprising chlorpyrifos and pyriproxyfen, as well as active pharmaceutical ingredients and preparations. In addition, the company offers chemical intermediates, including 2-chloropyridine; 2,3-dichloropyridine; 2,5-dichloropyridine; 2,6-dichloropyridine; 2,3,4-trichloropyridine; 2,3,5-trichloropyridine; 2,3,6-trichloropyridine; nitrapyrin; pentafluoropyridine; 2,3,5,6-tetrachloro-4-methylsulfonylpyridine; 6-chloropyridine-2-carbonitrile; 3,6-difluoropyridine-2-carboxylic acid; 2,2'-bipyridine; 2-chloro-4'-fluoroacetophenone; 2-chloro-2',4'-difluoroacetophenone; and 2-fluoro-3-nitrobenzoic acid. Further, its intermediates comprise (E)-4-(dimethylamino)but-2-enoic acid hydrochloride; 4,4'-dichloro-[3,3']bipyridinyl; clopyralid-methyl; methyl 3,4,6-trichloropicolinate; 2,4,5-trichloropyridine; 7-fluoro-6-nitro-4-hydroxyquinazoline; N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine; 4-bromocrotonic acid; 4-N-(3-chloro-4-fluorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine; 2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide; and 5-chloro-8-hydroxyquinoline. Lier Chemical Co.,LTD. was founded in 1993 and is headquartered in Mianyang, the People's Republic of China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7.85B | 10.14B | 6.49B | 4.97B | 4.16B | 4.03B | 3.08B | 1.98B | 1.49B | 1.32B | 1.44B | 1.28B | 936.01M | 445.31M | 394.21M | 404.00M | 304.02M | 262.80M | 172.57M |
Cost of Revenue | 6.06B | 6.89B | 4.42B | 3.53B | 3.09B | 2.70B | 2.20B | 1.50B | 1.13B | 1.03B | 1.12B | 986.42M | 731.45M | 314.30M | 237.52M | 259.50M | 159.60M | 136.25M | 85.20M |
Gross Profit | 1.79B | 3.24B | 2.08B | 1.44B | 1.08B | 1.33B | 886.17M | 480.20M | 359.26M | 289.88M | 320.77M | 291.68M | 204.56M | 131.02M | 156.69M | 144.50M | 144.42M | 126.56M | 87.37M |
Gross Profit Ratio | 22.76% | 31.98% | 32.00% | 28.95% | 25.86% | 33.07% | 28.74% | 24.22% | 24.13% | 22.00% | 22.27% | 22.82% | 21.85% | 29.42% | 39.75% | 35.77% | 47.50% | 48.16% | 50.63% |
Research & Development | 301.89M | 365.79M | 247.09M | 188.09M | 221.22M | 165.47M | 40.48M | 13.12M | 13.49M | 15.02M | 16.33M | 23.50M | 5.26M | 8.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 172.38M | 101.21M | 89.18M | 71.45M | 59.13M | 57.52M | 54.85M | 46.40M | 34.12M | 34.95M | 38.26M | 38.30M | 45.56M | 24.10M | 43.57M | 38.04M | 23.61M | 12.47M | 13.64M |
Selling & Marketing | 118.31M | 119.56M | 81.22M | 125.69M | 134.56M | 121.22M | 89.21M | 71.33M | 61.98M | 47.13M | 40.11M | 44.30M | 31.55M | 17.00M | 13.51M | 10.23M | 8.21M | 8.51M | 7.95M |
SG&A | 527.13M | 220.77M | 170.41M | 197.13M | 193.69M | 178.74M | 144.06M | 117.72M | 96.10M | 82.09M | 78.37M | 82.59M | 77.11M | 41.10M | 57.08M | 48.27M | 31.82M | 20.98M | 21.59M |
Other Expenses | 76.70M | 269.13M | 202.03M | 147.81M | 131.92M | -35.63M | -13.69M | 24.13M | 18.63M | 11.56M | 15.63M | 22.95M | 29.86M | 6.09M | 1.52M | 1.53M | 5.18M | 101.12K | -1.73M |
Operating Expenses | 905.72M | 855.70M | 619.52M | 533.03M | 546.83M | 527.37M | 328.84M | 232.61M | 190.65M | 162.53M | 145.93M | 152.10M | 125.81M | 74.15M | 57.08M | 48.29M | 31.83M | 20.98M | 22.22M |
Cost & Expenses | 6.97B | 7.75B | 5.04B | 4.06B | 3.63B | 3.22B | 2.53B | 1.73B | 1.32B | 1.19B | 1.27B | 1.14B | 857.25M | 388.44M | 294.60M | 307.79M | 191.42M | 157.23M | 107.42M |
Interest Income | 15.11M | 18.50M | 9.41M | 10.05M | 8.96M | 7.62M | 4.27M | 1.71M | 617.94K | 1.15M | 2.25M | 3.32M | 4.35M | 21.22M | 9.50M | 844.10K | 315.43K | 158.24K | 1.92M |
Interest Expense | 52.24M | 65.97M | 88.71M | 95.77M | 83.31M | 49.85M | 13.22M | 11.56M | 21.91M | 11.01M | 1.42M | 399.09K | 83.90K | 1.53M | 242.86K | 2.33M | 1.07M | 176.83K | 110.44K |
Depreciation & Amortization | 630.90M | 568.43M | 497.51M | 390.24M | 348.19M | 261.04M | 186.29M | 144.61M | 109.33M | 82.47M | 59.13M | 50.12M | 39.85M | 22.83M | 13.52M | 9.29M | 6.81M | 5.48M | 5.25M |
EBITDA | 1.56B | 3.01B | 1.91B | 1.26B | 869.55M | 1.05B | 714.28M | 415.02M | 277.21M | 204.51M | 194.82M | 189.95M | 138.97M | 99.88M | 121.87M | 98.12M | 117.97M | 108.16M | 67.77M |
EBITDA Ratio | 19.88% | 29.79% | 29.34% | 25.42% | 20.78% | 26.33% | 23.16% | 21.80% | 20.69% | 16.82% | 16.06% | 16.68% | 15.63% | 22.60% | 31.16% | 25.09% | 39.00% | 41.73% | 40.36% |
Operating Income | 881.30M | 2.43B | 1.37B | 772.99M | 432.06M | 767.24M | 524.84M | 244.28M | 155.23M | 110.05M | 142.90M | 139.62M | 72.28M | 69.91M | 107.82M | 86.62M | 105.45M | 103.74M | 65.92M |
Operating Income Ratio | 11.23% | 23.96% | 21.07% | 15.56% | 10.38% | 19.05% | 17.02% | 12.32% | 10.42% | 8.35% | 9.92% | 10.92% | 7.72% | 15.70% | 27.35% | 21.44% | 34.69% | 39.48% | 38.20% |
Total Other Income/Expenses | -4.13M | -61.47M | -40.09M | 251.29K | 7.99M | -23.46M | -13.45M | 13.46M | 12.97M | 3.53M | -8.63M | -1.89M | 27.04M | 21.80M | 8.97M | -8.62M | -2.50M | -1.24M | -3.52M |
Income Before Tax | 877.17M | 2.37B | 1.33B | 773.24M | 440.05M | 743.78M | 511.40M | 258.38M | 168.20M | 113.58M | 134.27M | 137.69M | 99.32M | 75.52M | 108.35M | 87.59M | 110.09M | 102.51M | 62.40M |
Income Before Tax Ratio | 11.17% | 23.35% | 20.45% | 15.56% | 10.57% | 18.47% | 16.58% | 13.03% | 11.30% | 8.62% | 9.32% | 10.77% | 10.61% | 16.96% | 27.48% | 21.68% | 36.21% | 39.01% | 36.16% |
Income Tax Expense | 109.92M | 341.88M | 165.41M | 102.70M | 53.48M | 92.31M | 72.74M | 34.87M | 23.45M | 18.39M | 19.44M | 18.61M | 10.06M | 3.79M | 7.19M | -82.38K | 3.07M | 3.09M | 5.05M |
Net Income | 603.89M | 1.81B | 1.07B | 612.21M | 311.14M | 577.81M | 401.97M | 208.35M | 138.45M | 92.41M | 104.09M | 87.62M | 69.62M | 71.74M | 101.15M | 87.68M | 107.02M | 99.44M | 57.37M |
Net Income Ratio | 7.69% | 17.88% | 16.51% | 12.32% | 7.47% | 14.35% | 13.04% | 10.51% | 9.30% | 7.01% | 7.23% | 6.86% | 7.44% | 16.11% | 25.66% | 21.70% | 35.20% | 37.84% | 33.24% |
EPS | 0.75 | 2.26 | 1.46 | 0.83 | 0.42 | 0.79 | 0.55 | 0.29 | 0.20 | 0.20 | 0.22 | 0.18 | 0.14 | 0.15 | 0.21 | 0.21 | 0.30 | 0.52 | 0.30 |
EPS Diluted | 0.75 | 2.26 | 1.39 | 0.80 | 0.42 | 0.77 | 0.55 | 0.29 | 0.20 | 0.20 | 0.22 | 0.18 | 0.14 | 0.15 | 0.21 | 0.21 | 0.30 | 0.52 | 0.30 |
Weighted Avg Shares Out | 800.49M | 800.44M | 735.37M | 734.13M | 734.13M | 734.13M | 734.05M | 729.22M | 692.27M | 472.95M | 480.48M | 479.72M | 482.07M | 482.53M | 476.27M | 416.01M | 356.54M | 191.89M | 192.93M |
Weighted Avg Shares Out (Dil) | 800.49M | 800.44M | 771.14M | 760.58M | 734.13M | 754.32M | 734.09M | 729.22M | 692.27M | 472.95M | 480.48M | 479.72M | 482.07M | 482.53M | 476.27M | 416.01M | 356.54M | 191.89M | 192.93M |
Source: https://incomestatements.info
Category: Stock Reports